Scotiabank Weighs in on Savaria's FY2026 Earnings (TSE:SIS)

Key Points

• Scotiabank lowered its FY2026 EPS forecast for Savaria to C$1.34 from C$1.38, though that remains above the current consensus estimate of C$1.20.
• Savaria reported quarterly EPS of C$0.32 and revenue of C$245.03 million, with a 9.44% net margin and 13.59% return on equity.
• Analyst sentiment remains positive: one analyst rates Savaria Strong Buy and nine rate it Buy, with an average price target of C$34.35.

Savaria Co. (TSE:SIS - Free Report) - Investment analysts at Scotiabank dropped their FY2026 earnings per share estimates for shares of Savaria in a research note issued to investors on Wednesday, November 11th. Scotiabank analyst J. Goldman now forecasts that the company will post earnings of $1.34 per share for the year, down from their previous forecast of $1.38. The consensus estimate for Savaria's current full-year earnings is $1.20 per share.

Savaria (TSE:SIS - Get Free Report) last issued its quarterly earnings data on Wednesday, November 4th. The company reported C$0.32 EPS for the quarter. Savaria had a net margin of 9.44% and a return on equity of 13.59%. The firm had revenue of C$245.03 million for the quarter.

A number of other equities research analysts have also issued reports on the company. Ventum Financial set a C$34.50 target price on Savaria and gave the company a "buy" rating in a research note on Thursday, September 10th. Desjardins began coverage on Savaria in a report on Wednesday, November 4th. They issued a "moderate buy" rating for the company. TD upped their price objective on Savaria from C$35.00 to C$37.00 and gave the company a "buy" rating in a research report on Friday, August 7th. TD Securities raised shares of Savaria to a "strong-buy" rating in a research note on Friday, July 24th. Finally, ATB Cormark Capital Markets upped their target price on shares of Savaria from C$35.00 to C$38.00 and gave the company an "outperform" rating in a report on Friday, August 7th. One research analyst has rated the stock with a Strong Buy rating and nine have given a Buy rating to the company. According to MarketBeat, the company presently has an average rating of "Buy" and an average price target of C$34.35.

Savaria Stock Performance

Shares of SIS opened at C$29.46 on Friday. The company has a current ratio of 1.67, a quick ratio of 0.91 and a debt-to-equity ratio of 26.86. The company has a 50-day moving average of C$29.32 and a two-hundred day moving average of C$28.36. Savaria has a 12-month low of C$20.72 and a 12-month high of C$31.95. The stock has a market cap of C$2.12 billion, a P/E ratio of 23.38, a PEG ratio of 42.72 and a beta of 0.58.

Insider Buying and Selling

In related news, insider Jean-Philippe De Montigny sold 10,000 shares of Savaria stock in a transaction on Monday, September 21st. The stock was sold at an average price of C$29.21, for a total value of C$292,100.00. Following the transaction, the insider owned 82,560 shares in the company, valued at approximately C$2,411,577.60. This trade represents a 10.80% decrease in their ownership of the stock. Also, Director Les Teague sold 5,000 shares of the stock in a transaction that occurred on Tuesday, September 22nd. The stock was sold at an average price of C$29.52, for a total transaction of C$147,600.00. 17.45% of the stock is currently owned by insiders.

Savaria Company Profile

Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.